Altynay Shigayeva1, Wallis Rudnick2, Karen Green1, Gregory Tyrrell3, Walter H B Demczuk4, Wayne L Gold5, Jonathan Gubbay6, Frances Jamieson6, Agron Plevneshi1, Sylvia Pong-Porter1, Susan Richardson7, Allison McGeer8. 1. Mount Sinai Hospital, Toronto, Canada. 2. Mount Sinai Hospital, Toronto, Canada; University of Toronto, Toronto, Canada. 3. Alberta Provincial Public Health Laboratory, Edmonton, Alberta, Canada. 4. National Microbiology Laboratory, Winnipeg, Manitoba, Canada. 5. University of Toronto, Toronto, Canada; University Health Network, Toronto, Canada. 6. University of Toronto, Toronto, Canada; Public Health Ontario, Toronto, Canada. 7. University of Toronto, Toronto, Canada; Hospital for Sick Children, Toronto, Canada. 8. Mount Sinai Hospital, Toronto, Canada; University of Toronto, Toronto, Canada. Electronic address: amcgeer@mtsinai.on.ca.
Abstract
BACKGROUND: Pneumococcal disease burden is difficult to quantify due to limited data regarding non-bacteremic disease. We assessed serotype-specific differences in pneumococcal disease presentations in adults in Toronto, Canada. METHODS: From 2003 to 2011, population-based surveillance for invasive pneumococcal disease was conducted and respiratory pneumococcal isolates collected in Metropolitan Toronto/Peel Region, Canada. Episodes of care were classified into disease categories. RESULTS: Of 3105 eligible cases of IPD, 2060 cases were bacteremic pneumonia, and 1045 bacteremia without pneumonia. Of 2751 eligible respiratory cases, 1542 (56.0%) were non-bacteremic pneumonia (NBPP), 467 (17.0%) were other acute respiratory infection (oARI), and 742 (27.0%) were isolates representing colonization. Serotypes 3 (11.3%), 19A (8.4%) and 22F (6.2%) were the most common; serotypes 1,5, and 8 were rare. Serotypes 4, 14, 7F, 9V, 12F, 14, 19A and 6C were over-represented in bacteremic disease, and serotypes 3, 6A, 11A, 19F, 23A, 23F, 35B, 35F were more common in NBPP. The proportion of cases due to PCV7 serotypes declined from 48.7% to 8.7% in bacteremic pneumonia, from 35.3% to 10.9% in NBPP, from 34.2% to 7.5% in oARI, and from 38.7% to 12.2% in colonizing isolates. In 2010-2011, PCV13 serotypes accounted for 62.6% of isolates associated with bacteremic pneumonia, 42.0% of bacteremia without pneumonia, 41.1% of NBPP, 25.7% of oARI, and 32.9% of colonizing isolates. CONCLUSIONS: Serotype distributions differ significantly in different presentations of pneumococcal disease. Herd protection due to PCV7 has changed serotype distribution, but PCV13 serotypes remain important in all categories of disease.
BACKGROUND:Pneumococcal disease burden is difficult to quantify due to limited data regarding non-bacteremic disease. We assessed serotype-specific differences in pneumococcal disease presentations in adults in Toronto, Canada. METHODS: From 2003 to 2011, population-based surveillance for invasive pneumococcal disease was conducted and respiratory pneumococcal isolates collected in Metropolitan Toronto/Peel Region, Canada. Episodes of care were classified into disease categories. RESULTS: Of 3105 eligible cases of IPD, 2060 cases were bacteremic pneumonia, and 1045 bacteremia without pneumonia. Of 2751 eligible respiratory cases, 1542 (56.0%) were non-bacteremic pneumonia (NBPP), 467 (17.0%) were other acute respiratory infection (oARI), and 742 (27.0%) were isolates representing colonization. Serotypes 3 (11.3%), 19A (8.4%) and 22F (6.2%) were the most common; serotypes 1,5, and 8 were rare. Serotypes 4, 14, 7F, 9V, 12F, 14, 19A and 6C were over-represented in bacteremic disease, and serotypes 3, 6A, 11A, 19F, 23A, 23F, 35B, 35F were more common in NBPP. The proportion of cases due to PCV7 serotypes declined from 48.7% to 8.7% in bacteremic pneumonia, from 35.3% to 10.9% in NBPP, from 34.2% to 7.5% in oARI, and from 38.7% to 12.2% in colonizing isolates. In 2010-2011, PCV13 serotypes accounted for 62.6% of isolates associated with bacteremic pneumonia, 42.0% of bacteremia without pneumonia, 41.1% of NBPP, 25.7% of oARI, and 32.9% of colonizing isolates. CONCLUSIONS: Serotype distributions differ significantly in different presentations of pneumococcal disease. Herd protection due to PCV7 has changed serotype distribution, but PCV13 serotypes remain important in all categories of disease.
Authors: Marta Di Pasquale; Stefano Aliberti; Chara Azzari; Maria Moriondo; Francesco Nieddu; Francesco Blasi; Marco Mantero Journal: SAGE Open Med Date: 2017-07-16
Authors: Philipp P Kohler; Roberto G Melano; Samir N Patel; Shumona Shafinaz; Amna Faheem; Brenda L Coleman; Karen Green; Irene Armstrong; Huda Almohri; Sergio Borgia; Emily Borgundvaag; Jennie Johnstone; Kevin Katz; Freda Lam; Matthew P Muller; Jeff Powis; Susan M Poutanen; David Richardson; Anu Rebbapragada; Alicia Sarabia; Andrew Simor; Allison McGeer Journal: Emerg Infect Dis Date: 2018-09 Impact factor: 6.883
Authors: Marco Mantero; Stefano Aliberti; Chiara Azzari; Maria Moriondo; Francesco Nieddu; Francesco Blasi; Marta Di Pasquale Journal: Ther Adv Respir Dis Date: 2017-08-31 Impact factor: 4.031
Authors: Shinthuja Wijayasri; Kelty Hillier; Gillian H Lim; Tara M Harris; Sarah E Wilson; Shelley L Deeks Journal: PLoS One Date: 2019-12-13 Impact factor: 3.240